| VIEW POINT |
|
| Year : 2017 | Volume
: 6
| Issue : 2 | Page : 73-77 |
|
|
Risk assessment, risk management, and prevention of acute vascular events
Gundu H R Rao
Department of Laboratory Medicine and Pathology, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota, USA
Correspondence Address:
Gundu H R Rao
Thrombosis Research, Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2250-3528.203529
|
|
|
South Asians have a very high incidence of cardiometabolic diseases such as hypertension, central abdominal obesity, metabolic syndrome, type 2 diabetes, heart disease, and stroke. In spite of the fact that common risk factors associated with these clinical conditions are known, we do not have point-of-care assays, to monitor the disease of the vessels, and the efficacy of antiplatelet therapy. We have a window of opportunity to develop three-dimensional ultrasound methodologies, to monitor the subclinical atherosclerosis, altered flow velocities of regional vascular beds, as well as plaque progression and regression in the major vessels. We also have opportunities to develop state-of-the-art methodologies for monitoring the efficacy or otherwise of antiplatelet therapies. In this overview, we share our views and strategies for the development of affordable medical technologies in India, for monitoring vessel wall pathology as well as for better management of antiplatelet therapies. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
